Mylan offers to buy Swedish pharma firm Meda for $9.9 bn
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
Feb 11, 2016, 07:29 AM IST
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
Feb 11, 2016, 07:29 AM IST